Cent Eur J Public Health 2014, 22(3):207

Ebola Hemorrhagic Fever: Case Fatality Rate 90%?

Mohamed Farouk Allam1,2
1 Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Cordoba, Cordoba, Spain
2 Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Klíčová slova: Ebola, Ebola hemorrhagic fever, case fatality rate, epidemic

Vloženo: 15. srpen 2014; Revidováno: 1. září 2014; Přijato: 1. září 2014; Zveřejněno: 1. září 2014  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Allam MF. Ebola Hemorrhagic Fever: Case Fatality Rate 90%? Cent Eur J Public Health. 2014;22(3):207. PubMed PMID: 25438402.
Sdílet...
Stáhnout citaci
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Zobrazit celý článek

    Reference

    1. World Health Organization. Ebola virus disease. Fact sheet no. 103 [Internet]. Geneva: WHO; 2014 [updated 2014 Apr; cited 2014 Aug 5]. Available from: http://www.who.int/mediacentre/factsheets/fs103/en/.
    2. World Health Organization. Global Alert and Response (GAR). Ebola virus disease update - West Africa. Disease outbreak news [Internet]. Geneva: WHO; 2014 [cited 2014 Aug 5]. Available from: http://www.who.int/csr/don/2014_08_04_ebola/en/.
    3. National Institute of Allergy and Infectious Diseases. Ebola/Marburg. Ebola/Marburg research [Internet]. Bethesda: National Institute ofAllergy and Infectious Diseases; 2014 [cited 2014Aug 5].Available from: http://www.niaid.nih.gov/topics/ebolamarburg/research/Pages/default.aspx.
    4. Mupapa K, Massamba M, Kibadi K, Kuvula K, Bwaka A, Kipasa M, et al; International Scientific and Technical Committee. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. J Infect Dis. 1999 Feb;179 Suppl 1:S18-23. Přejít k původnímu zdroji... Přejít na PubMed...
    5. Warren TK, Wells J, Panchal RG, Stuthman KS, Garza NL, Van Tongeren SA, et al. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature. 2014 Apr 17;508(7496):402-5. Přejít k původnímu zdroji... Přejít na PubMed...

    Zpět na obsah